What is a moderate dose of simvastatin (statin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Moderate-Dose Simvastatin Definition

Moderate-intensity simvastatin is defined as 20-40 mg once daily, which achieves a 30-49% reduction in LDL cholesterol. 1

Statin Intensity Classification

The American Diabetes Association and American College of Cardiology classify statin therapy into two main intensity categories based on LDL cholesterol reduction 1:

Moderate-Intensity Statins (30-49% LDL-C reduction)

  • Simvastatin 20-40 mg daily 1
  • Atorvastatin 10-20 mg 1
  • Rosuvastatin 5-10 mg 1
  • Pravastatin 40-80 mg 1
  • Fluvastatin XL 80 mg 1

High-Intensity Statins (≥50% LDL-C reduction)

  • Atorvastatin 40-80 mg 1
  • Rosuvastatin 20-40 mg 1

Critical Dosing Restrictions for Simvastatin

The maximum recommended dose of simvastatin is 40 mg daily for most patients. 2 The FDA has restricted simvastatin 80 mg to only those patients who have been taking it chronically (≥12 months) without evidence of muscle toxicity, due to increased myopathy risk 3, 2.

Mandatory Dose Reductions with Drug Interactions

When simvastatin is combined with certain medications, the dose must be reduced 2:

  • With verapamil, diltiazem, or dronedarone: Do not exceed 10 mg daily 4, 2
  • With amiodarone, amlodipine, or ranolazine: Do not exceed 20 mg daily 4, 2
  • With lomitapide: Reduce dose by 50%, not exceeding 20 mg daily 2

These restrictions exist because simvastatin is extensively metabolized by CYP3A4, and these medications significantly increase simvastatin exposure, raising myopathy risk 4, 5.

Clinical Context for Moderate-Intensity Simvastatin

For primary prevention in diabetes patients aged 40-75 years without established cardiovascular disease, moderate-intensity statin therapy (including simvastatin 20-40 mg) is recommended. 1

However, for higher-risk patients with additional cardiovascular risk factors or established atherosclerotic cardiovascular disease, high-intensity statin therapy is preferred to achieve ≥50% LDL-C reduction and target LDL-C <70 mg/dL 1. In these cases, atorvastatin 40-80 mg or rosuvastatin 20-40 mg should be used instead of simvastatin, as simvastatin cannot safely achieve high-intensity lipid lowering 3.

Special Populations Requiring Caution

Exercise particular caution with simvastatin in 4:

  • Elderly patients, especially thin or frail women
  • Patients with severe renal impairment (start at 5 mg daily) 2
  • Patients with diabetes combined with chronic renal failure
  • Patients of Asian descent

Practical Equivalency

Simvastatin 40 mg provides approximately 41% LDL-C reduction, making it equivalent to atorvastatin 20 mg (43% reduction) in moderate-intensity therapy. 6, 5 At doses of 20-40 mg, simvastatin lowers LDL cholesterol by 35-45% 5, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Stronger Statin Options for Intensive Lipid-Lowering Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Simvastatin Drug Interactions and Dose Modifications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Simvastatin: present and future perspectives.

Expert opinion on pharmacotherapy, 2007

Guideline

Switching from Atorvastatin 20 mg to Simvastatin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Simvastatin: a review.

Expert opinion on pharmacotherapy, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.